Open Access Articles

Rebecca Penrose
Lisa Beatty
Julie Mattiske
Bogda Koczwara
CJON 2013, 17(2), 188-193 DOI: 10.1188/13.CJON.188-193
The objective of the current article was to assess the psychosocial impact of treatment-related infertility or the possibility of infertility on young women with cancer in contrast to the general population. Literature on the subject of female infertility among the general population and treatment-...
No votes yet
Marcelle Kaplan
Suzanne M. Mahon
CJON 2013, 17(2), 174-179 DOI: 10.1188/13.CJON.174-179
Cancer intervention strategies have been increasingly focused on developing therapies that are personalized and tailored to each individual's unique genetic profile. Evolving understanding of the metabolism and pharmacogenomics of tamoxifen, an early example of targeted therapy for women with...
No votes yet
Denice Economou
Arti Hurria
Marcia Grant
CJON 2012, 16(3), E78-E85 DOI: 10.1188/12.CJON.E78-E83
Older adults constitute the greatest percentage of cancer survivors in the country, with 61% being aged 65 years and older. Assessing older adult cancer survivors beyond chronological age to include changes in functional status is an essential process to help nurses anticipate cancer treatment...
No votes yet
Joanne Lester
CJON 2012, 16(6), E192-E197 DOI: 10.1188/12.CJON.E192-E197
The use of hormonal, chemotherapeutic, and targeted biologic oral agents has exponentially increased since the early 2000s. Oral therapies have the advantage of persistent exposure of the cytotoxic drug to tumor cells and the tumor environment. The use of oral anticancer agents provides therapeutic...
No votes yet
Marlyn Allicock
Leanne Kaye
La-Shell Johnson
Carol Carr
Candice Alick
Mindy Gellin
Marci Campbell
CJON 2012, 16(5), E156-E163 DOI: 10.1188/12.CJON.E156-E163
Motivational interviewing (MI) as a counseling approach has gained empirical support for its use in a number of settings and for a variety of behaviors. However, the majority of practitioners trained to use MI have been professionals rather than laypeople. This article presents the rationale,...
No votes yet
Eric Zack
CJON 2012, 16(4), E125-E132 DOI: 10.1188/12.CJON.E125-E132
New trends have emerged in treating patients with autoimmune diseases with medications traditionally used in oncology. This article will summarize a comprehensive literature review performed to identify effective chemotherapy and biotherapeutic agents for treating each of the main autoimmune...
No votes yet
Rebecca H. Lehto
CJON 2012, 16(1), E4-E11 DOI: 10.1188/12.CJON.E1-E8
A new diagnosis of lung cancer is a highly threatening experience that raises personally relevant existential issues and brings death-related thoughts and concerns to mind. Those issues can be very disturbing to patients, leading to distress and potentially to a lowered quality of life. The purpose...
No votes yet
Mary Beth Steck
Julia A. Eggert
CJON 2011, 15(3), E34-E41 DOI: 10.1188/11.CJON.E34-E41
Genetic advancements have presented numerous discrimination predicaments to individuals, the healthcare community, and legislators at state and federal levels. Oncology nurses should be knowledgeable about the Genetic Information Nondiscrimination Act of 2008 (GINA) and its applications to clinical...
No votes yet
Journal Club
Open Access Article
Kathryn Trotter
Alana Frazier
Colleen K. Hendricks
Heidi Scarsella
CJON 2011, 15(2), E24-E33 DOI: 10.1188/11.CJON.E24-E33
The Centering Cancer Survivorship (CCS) follow-up care program is an innovation in healthcare delivery that meets the needs of cancer survivors and cancer centers. Piloted in a breast cancer clinic, the program provides an avenue for provision of psychological support and health-promotion...
No votes yet
Amy Edgington
Mary Ann Morgan
CJON 2011, 15(1), E3-E12 DOI: 10.1188/11.CJON.E3-E12
Cancer recurrence is a very real concern for cancer survivors. Surveillance for recurrence and vigilance for development of new cancers are top priorities during follow-up visits after active treatment ends. However, the cancer survivor also is at risk for the development of comorbid conditions...
No votes yet